@article{180a75ace8e74e84be48468f5a70ee45,
title = "Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective",
keywords = "Abaloparatide, Alendronate, Economic evaluation, Monotherapy, Osteoporosis, Sequential treatmen, QUALITY-OF-LIFE, POSTMENOPAUSAL WOMEN, ORAL BISPHOSPHONATES, VERTEBRAL FRACTURES, SEVERE OSTEOPOROSIS, ECONOMIC-EVALUATION, EXCESS MORTALITY, UNITED-STATES, HIP FRACTURE, HEALTH",
author = "Mickael Hiligsmann and Williams, {Setareh A.} and Fitzpatrick, {Lorraine A.} and Silverman, {Stuart S.} and Richard Weiss and Jean-Yves Reginster",
year = "2020",
month = jun,
doi = "10.1016/j.semarthrit.2020.02.004",
language = "English",
volume = "50",
pages = "394--400",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W B Saunders Co-Elsevier Inc ",
number = "3",
}